Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
AMGEN Inc's leukaemia drug Blincyto will cost US$178,000 for a standard course of treatment, continuing a trend of high prices for immunotherapy, the newest wave of cancer treatments.
The price includes two US$89,000 cycles of therapy, the median duration of treatment...